Related Experiment Video
Updated: May 28, 2026
Isolation of Papillary and Reticular Fibroblasts from Human Skin by Fluorescence-activated Cell Sorting
Published on: May 7, 2019
Therapeutic utilities of fibroblast growth factor 19
Introduction:
Diabetes and associated metabolic conditions have reached pandemic proportions worldwide and there is a clear unmet medical need for new therapies that are both effective and safe. FGF19 is a distinctive member of the FGF family that functions as an endocrine hormone.
Areas Covered:
An up-to-date report on the exciting findings related to the involvement of FGF19 in the regulation of glucose, bile acid metabolism and energy expenditure. The role of FGF receptors in these different activities. The therapeutic potential of FGF19 and the engineering opportunities for removing undesirable mitogenic activity.
Expert Opinion:
The ability of FGF19 to regulate bile acid homeostasis, gallbladder filling and tumor development and its potent ability to normalize glucose, lipid and energy homeostasis have made it a potential therapeutic target for the treatment of patients with gallstones, cancer and metabolic diseases, among others. Its potential utility as a novel therapeutic for both type 1 and type 2 diabetes is of particular interest. The ability to separate the undesired mitogenic activity from its potent metabolic activities has opened new opportunities for the development of potential therapeutic molecules based on FGF19 in treating various conditions associated with metabolic syndrome.
Insights
Fibroblast Growth Factor 19 (FGF19) shows promise for treating metabolic diseases like diabetes by regulating glucose and energy. Researchers are exploring its therapeutic potential, aiming to enhance its benefits while minimizing side effects.
Area of Science:
- Endocrinology
- Metabolic disease research
- Drug development
Background:
- Metabolic conditions and diabetes are global health crises with limited effective treatments.
- Fibroblast Growth Factor 19 (FGF19) is an endocrine hormone with significant physiological roles.
Purpose of the Study:
- To review the role of FGF19 in regulating glucose metabolism, bile acid homeostasis, and energy expenditure.
- To explore the therapeutic potential of FGF19 and strategies to mitigate its mitogenic activity.
Main Methods:
- Literature review of current findings on FGF19.
- Analysis of FGF receptor involvement in FGF19's functions.
- Discussion of FGF19 engineering for therapeutic applications.
Main Results:
- FGF19 influences glucose, bile acid, and energy metabolism.
- FGF receptors mediate FGF19's diverse biological activities.
- Engineering FGF19 can separate metabolic benefits from mitogenic effects.
Conclusions:
- FGF19's ability to regulate key metabolic pathways makes it a promising therapeutic target for metabolic syndrome, diabetes, and related conditions.
- Separating FGF19's metabolic and mitogenic activities creates opportunities for developing safer, more effective FGF19-based therapies.
- FGF19 holds particular interest for treating type 1 and type 2 diabetes.
